Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM - News), announced today that Cathy Bradshaw, President, was interviewed by the Zangani Investor Community on their advanced wound care collagen product, CellerateRx®. Ms. Bradshaw briefly discussed some of the recent announcements of the company, distinguishing unique product characteristics and plans for international distribution. "It was a pleasure to be interviewed by the Zangani Investor Community," states Cathy Bradshaw. "We are excited about the recent agreement with Dr. Shapiro, the publication of the case reports in Advances in Skin & Wound Care, as well as the other recent announcements. These will enable us to increase revenues through additional sales and other distribution arrangements which the company has in the works."

The entire interview is available at:

http://www.zangani.com/webcasts/20080903/woundcare

www.zangani.com - Available Online and via Podcast.

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTCBB: WNDM - News), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at www.Celleraterx.com .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.